INmune Bio targets Ebstrocel U.K. MAA by end of Q3 or early Q4 2026 while outlining $1M-$1.5M monthly burn — See source for full details.
$INMB
Price history, market instrument context, member research, and related headlines in one place.
INMB key statistics
NasdaqCMUSD
52-week range
$1.0934%$2.60
Latest session $1.59–$1.92INmune Bio Inc. (INMB) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $1.60, down $0.08 (4.76%) from the previous close of $1.68. It has traded between $1.59 and $1.92 in the latest session. Over the past year it has ranged from $1.09 to $2.60, leaving it in the lower half of its 52-week range (34%). Reported volume for the session was 1.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $INMB research…